Terms: = Liver cancer AND Ki-67 AND Prognosis
304 results:
1. Sarcomatoid hepatocellular carcinoma: A case report and review of the literature.
Hu C; Zhao M; Wei Q; Chen Z; Zhao B
Medicine (Baltimore); 2024 Mar; 103(13):e37641. PubMed ID: 38552058
[TBL] [Abstract] [Full Text] [Related]
2. Frequent expression of PD-L1 in BLS-type diffuse large B-cell lymphoma: implications for aggressiveness and immunotherapy.
Yang CF; Yu YT; Wang SH; Chen YP; Chen TY; Hsu CY; Medeiros LJ; Chang KC
Pathology; 2024 Apr; 56(3):367-373. PubMed ID: 38290893
[TBL] [Abstract] [Full Text] [Related]
3. Downregulation of MTHFD2 Inhibits Proliferation and Enhances Chemosensitivity in Hepatocellular Carcinoma via PI3K/AKT Pathway.
Wang J; Yu Z; Jiang Y; Le T; Wu Y; Li Z; Zhang G; Wu F; Ma H
Front Biosci (Landmark Ed); 2024 Jan; 29(1):35. PubMed ID: 38287824
[TBL] [Abstract] [Full Text] [Related]
4. Usefulness of intratumoral perfusion analysis for assessing biological features of non-functional pancreatic neuroendocrine neoplasm.
Notake T; Shimizu A; Kubota K; Sugenoya S; Umemura K; Goto T; Yamada A; Fujinaga Y; Soejima Y
Langenbecks Arch Surg; 2024 Jan; 409(1):38. PubMed ID: 38221590
[TBL] [Abstract] [Full Text] [Related]
5. The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast cancer: A Multicenter Cross-Sectional Study in Indonesia.
Tenggara JB; Rachman A; Prihartono J; Lisnawati L; Panigoro SS; Heriyanto DS; Steven R; Tandarto K; Juanputra S; Sudoyo AW
Acta Med Indones; 2023 Oct; 55(4):376-384. PubMed ID: 38213050
[TBL] [Abstract] [Full Text] [Related]
6. [Clinicopathological features of intravascular large B-cell lymphoma and collision tumors of five cases].
Liu J; Liu GZ; Xia L; Wang HY; Zhang XF; Liu H
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):22-28. PubMed ID: 38178742
[No Abstract] [Full Text] [Related]
7. Efficacy, safety, and predictive model of Palbociclib in the treatment of HR-positive and HER2-negative metastatic breast cancer.
Wang W; Lei W; Fang Z; Jiang R; Wang X
BMC Cancer; 2024 Jan; 24(1):1. PubMed ID: 38166784
[TBL] [Abstract] [Full Text] [Related]
8. Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network.
Perrier M; Brugel M; Gérard L; Goichot B; Lièvre A; Lepage C; Hautefeuille V; Do Cao C; Smith D; Thuillier P; Cros J; Cadiot G; Walter T; de Mestier L
Eur J Endocrinol; 2023 Dec; 189(6):575-583. PubMed ID: 38039101
[TBL] [Abstract] [Full Text] [Related]
9. Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM.
Ingenerf M; Karim H; Auernhammer C; Zacherl M; Wenter V; Winkelmann M; Ricke J; Berger F; Schmid-Tannwald C
Radiol Oncol; 2023 Dec; 57(4):436-445. PubMed ID: 38038419
[TBL] [Abstract] [Full Text] [Related]
10. Optimal first-line treatment strategies of systemic therapy for unresectable gastrointestinal neuroendocrine tumors based on the opinions of Japanese experts.
Honma Y; Ikeda M; Hijioka S; Matsumoto S; Ito T; Aoki T; Furuse J
Invest New Drugs; 2023 Dec; 41(6):777-786. PubMed ID: 37856005
[TBL] [Abstract] [Full Text] [Related]
11. Treating rare tumors with liver transplantation.
Melehy A; Agopian V
Curr Opin Organ Transplant; 2024 Feb; 29(1):30-36. PubMed ID: 37851086
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic and pathological implications of contrast-enhanced ultrasound features in hepatocellular carcinoma.
Wang Y; Chai S; Cai W; Yu J; Liang P
J Cancer Res Ther; 2023 Aug; 19(4):1040-1047. PubMed ID: 37675734
[TBL] [Abstract] [Full Text] [Related]
13. [Analysis of clinicopathological features of 18 cases of hepatic angiosarcoma].
Zhou YY; Wang H; Xian ZH; Cong WM; Dong H
Zhonghua Gan Zang Bing Za Zhi; 2023 Jul; 31(7):729-735. PubMed ID: 37580256
[No Abstract] [Full Text] [Related]
14. [A Case of Breast Carcinoma That Changed Subtype to Squamous Cell Carcinoma after Chemotherapy].
Konishi K; Araya J; Nagabuchi M; Sakamoto T; Ogino J; Hirano S
Gan To Kagaku Ryoho; 2023 Jul; 50(7):825-827. PubMed ID: 37496230
[TBL] [Abstract] [Full Text] [Related]
15. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
Cheng P; Wang QX; Wang LL; Guan J; Zhou Y; Zhang T; Su F; Chen LQ; Cao Y; Cheng H; Zou L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):896-901. PubMed ID: 37356957
[TBL] [Abstract] [Full Text] [Related]
16. Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients.
Gudmundsdottir H; Habermann EB; Vierkant RA; Starlinger P; Thiels CA; Warner SG; Smoot RL; Truty MJ; Kendrick ML; Halfdanarson TR; Nagorney DM; Cleary SP
Ann Surg Oncol; 2023 Aug; 30(8):4840-4851. PubMed ID: 37208566
[TBL] [Abstract] [Full Text] [Related]
17. [Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases].
Lai YM; Li ZW; Li H; Wu Y; Shi YF; Zhou LX; Lou YT; Cui CL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):262-269. PubMed ID: 37042136
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive Pan-cancer Analysis of KIF18A as a Marker for prognosis and Immunity.
Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
[TBL] [Abstract] [Full Text] [Related]
19. [Eight Cases of Breast cancer That Relapsed More Than Ten Years after Initial Treatment].
Yoshimura A; Ueda T; Tanaka T; Kirihataya Y; Soga M; Yokotani T
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1935-1937. PubMed ID: 36733049
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic impact of
Park HL; Lee SW; Hong JH; Lee J; Lee A; Kwon SJ; Park SY; Yoo IR
Cancer Imaging; 2023 Jan; 23(1):2. PubMed ID: 36600314
[TBL] [Abstract] [Full Text] [Related]
[Next]